Cellnovo Ltd. shareholders elected Pierre Chancel to the U.K.-based medical technology company's board.
Chancel has more than 30 years of experience in the pharmaceutical and medical device sectors. He most recently worked at Sanofi as senior vice president of the global diabetes division, where he oversaw strategy, research and development, and marketing and commercial activities, Cellnovo said in a statement.
Chancel will help the company as it focuses on boosting sales of its diabetes management system.
